Skip to contentT
Tenon Medical, Inc.
T
TNONWTenon Medical, Inc. Q4 2025 · 10-K
derived · Computed from the longer spans the company filed.
Revenue$1.48M$1.48Mderived+92.3% vs Q4 2024 Net Income-$2.83M-$2.83MderivedN/M vs Q4 2024 EPS, diluted—
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
Tenon Medical, Inc. · CIK 1560293 · Engraved from SEC EDGAR
Not derived. Share counts vary by quarter.
Gross Profitderived$1,017,000+188.1% Operating Incomederived-$2,866,000N/M Operating Cash Flowderived-$2,224,000N/M Free Cash Flowderived-$2,416,000N/M Margins · derivedGross margin68.7%+22.8 pt vs Q4 2024
Operating margin-193.5%+218.6 pt vs Q4 2024
Net margin-191.2%+209.7 pt vs Q4 2024
ended Dec 31, 2025 · filed Mar 27, 2026 · 86 d after period end